#1 Clinical Trials Search in Europe

Artemisia Vulgaris

This article discusses recent clinical trials investigating the use of Artemisia vulgaris (mugwort) extracts in allergy testing and immunotherapy. These studies aim to evaluate the effectiveness and safety of various formulations containing Artemisia vulgaris for diagnosing and treating allergies, particularly allergic rhinitis and rhinoconjunctivitis caused by mugwort pollen.

Table of Contents

What is Artemisia Vulgaris?

Artemisia vulgaris, commonly known as mugwort or common wormwood, is a plant species that has been used in traditional medicine for centuries. In modern medicine, it is primarily used as an allergen extract for diagnostic purposes and potential treatment of allergies.[1]

Medical Uses

The primary medical use of Artemisia vulgaris in the context provided is for allergy diagnosis and potentially for immunotherapy. It is used in the form of a skin prick test solution to diagnose allergies to this specific plant.[1]

Artemisia vulgaris is classified under the ATC code V01AA02, which stands for “Allergen extracts, grass pollen”. This classification suggests that it is used similarly to grass pollen extracts in allergy testing and treatment.[1]

Administration Method

The Artemisia vulgaris extract is administered as a solution for skin-prick test. This means it is applied to the skin in a controlled manner to observe if an allergic reaction occurs. The typical dose is 1 drop, applied cutaneously (on the skin).[1]

Allergen Testing

Skin prick testing is a method used by allergists to determine if a patient is allergic to specific substances. During the test, a small amount of the Artemisia vulgaris extract is placed on the skin, usually on the forearm or back. The skin is then pricked through the drop with a small, sterile probe. If you’re allergic to Artemisia vulgaris, a small, itchy bump (wheal) surrounded by redness (flare) will appear at the test site within about 15 minutes.[1]

Precautions and Considerations

While the information provided doesn’t specify precautions for this particular allergen extract, it’s important to note that skin prick tests should be performed under medical supervision. Patients with a history of severe allergic reactions should inform their healthcare provider before undergoing such tests.[1]

It’s also worth noting that Artemisia vulgaris is part of a broader panel of allergen tests that may include other substances such as house dust mites, animal dander, and various pollens. Your healthcare provider will determine which specific allergens to test based on your medical history and symptoms.[1]

Aspect Details
Study Focus Efficacy and safety of Artemisia vulgaris (mugwort) extracts in allergy testing and immunotherapy
Target Conditions Moderate to severe allergic rhinitis/rhinoconjunctivitis due to mugwort pollen
Administration Methods Skin prick tests, sublingual immunotherapy, subcutaneous immunotherapy
Primary Endpoints Changes in Combined Symptom and Medication Score (CSMS), safety assessments
Secondary Endpoints Quality of life improvements, changes in specific IgE levels, nasal provocation test results
Participant Criteria Adults 18-65, confirmed mugwort allergy, moderate to severe symptoms, specific health requirements
Study Phases Phase II-III clinical trials

FAQ

  • What is Artemisia vulgaris and how is it used in allergy treatment? Artemisia vulgaris, commonly known as mugwort, is a plant used in allergy testing and treatment. Its pollen extract is used in skin prick tests to diagnose allergies and in immunotherapy solutions to help desensitize patients to mugwort allergies.
  • What types of allergies are being studied using Artemisia vulgaris extracts? The clinical trials are primarily focused on moderate to severe allergic rhinitis and rhinoconjunctivitis caused by mugwort pollen. Some studies also include patients with mild to moderate asthma related to these allergies.
  • How is Artemisia vulgaris administered in these clinical trials? Artemisia vulgaris extracts are being studied in different forms, including solutions for skin prick tests and formulations for sublingual immunotherapy (under the tongue) and subcutaneous immunotherapy (injections under the skin).
  • What are the main goals of these clinical trials? The primary objectives are to assess the efficacy and safety of Artemisia vulgaris extracts in diagnosing allergies and reducing allergy symptoms. Researchers are also trying to determine the most effective and best-tolerated doses for treatment.
  • Who can participate in these clinical trials? Generally, adults aged 18-65 with a confirmed allergy to mugwort pollen, experiencing moderate to severe allergy symptoms, and meeting specific health criteria are eligible. However, each trial has its own specific inclusion and exclusion criteria.

Ongoing Clinical Trials on Artemisia Vulgaris

  • Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

    Not recruiting

    3 1 1
    Investigated drugs:
    Austria Bulgaria Germany Latvia Lithuania Poland

Glossary

  • Allergic rhinitis: An allergic reaction affecting the nose, causing symptoms such as sneezing, runny nose, and nasal congestion in response to allergens like pollen.
  • Rhinoconjunctivitis: A combination of allergic symptoms affecting both the nose (rhinitis) and eyes (conjunctivitis), typically causing itching, redness, and watering of the eyes along with nasal symptoms.
  • Artemisia vulgaris: Also known as mugwort, it's a plant species whose pollen is a common cause of allergies and is used in allergy testing and immunotherapy treatments.
  • Immunotherapy: A treatment approach that aims to modify the immune system's response to allergens, typically by exposing the patient to gradually increasing amounts of the allergen to build tolerance.
  • Skin prick test: An allergy test where small amounts of suspected allergens are placed on the skin, which is then lightly pricked, to observe any allergic reactions.
  • Sublingual immunotherapy (SLIT): A form of allergy treatment where the allergen is placed under the tongue to be absorbed, aiming to increase tolerance to the allergen over time.
  • Subcutaneous immunotherapy (SCIT): An allergy treatment method where allergen extracts are injected under the skin to gradually build tolerance to the allergen.
  • Combined Symptom and Medication Score (CSMS): A measure used in allergy studies to assess the severity of allergy symptoms and the amount of medication needed to control them.
  • FEV1 (Forced Expiratory Volume in 1 second): A measure of lung function, representing the amount of air a person can forcefully exhale in one second.
  • Nasal Provocation Test (NPT): A diagnostic test where allergens are applied to the nasal mucosa to evaluate the allergic response and confirm a specific allergy.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effectiveness-of-purethal-mites-for-adults-with-moderate-to-severe-allergic-rhinitis-or-rhinoconjunctivitis-due-to-house-dust-mite-allergy/